Based on 1 publication(s) in Google Scholar
Liothyronine (Triiodothyronine) (GMP) is the Liothyronine (HY-A0070A) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. Liothyronine is a potent thyroid hormone receptors TRα and TRβ agonist with Kis of 2.33 nM for hTRα and hTRβ, respectively.
For research use only. We do not sell to patients.
- CAS No.: 6893-02-3
- Formula: C15H12I3NO4
- Molecular Weight:650.97
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Liothyronine (GMP)
More
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CHO | EC50 |
3.4 nM
Compound: T3
|
Agonist activity at human THRalpha expressed in CHO cells after 24 hrs by luciferase assay
Agonist activity at human THRalpha expressed in CHO cells after 24 hrs by luciferase assay
|
[PMID: 32356658] |
| CHO | EC50 |
6.2 nM
Compound: T3
|
Agonist activity at human THRbeta expressed in CHO cells after 24 hrs by luciferase assay
Agonist activity at human THRbeta expressed in CHO cells after 24 hrs by luciferase assay
|
[PMID: 32356658] |
| CHO-K1 | IC50 |
0.24 nM
Compound: 1
|
Binding affinity at human thyroid hormone receptor alpha 1 expressed in CHOK1 cells
Binding affinity at human thyroid hormone receptor alpha 1 expressed in CHOK1 cells
|
[PMID: 17543524] |
| CHO-K1 | IC50 |
0.26 nM
Compound: 1
|
Binding affinity at human thyroid hormone receptor beta-1 expressed in CHOK1 cells
Binding affinity at human thyroid hormone receptor beta-1 expressed in CHOK1 cells
|
[PMID: 17543524] |
| CV-1 | EC50 |
0.002 μM
Compound: T3
|
Agonist activity at human recombinant TRbeta1 transfected in CV-1 cells after 8 to 10 hrs by alkaline phosphatase reporter gene assay
Agonist activity at human recombinant TRbeta1 transfected in CV-1 cells after 8 to 10 hrs by alkaline phosphatase reporter gene assay
|
[PMID: 24290064] |
| CV-1 | EC50 |
0.0021 μM
Compound: T3
|
Agonist activity at human recombinant TRalpha1 transfected in CV-1 cells after 8 to 10 hrs by alkaline phosphatase reporter gene assay
Agonist activity at human recombinant TRalpha1 transfected in CV-1 cells after 8 to 10 hrs by alkaline phosphatase reporter gene assay
|
[PMID: 24290064] |
| CV-1 | EC50 |
0.5 nM
Compound: T3
|
Agonist activity at Xenopus laevis THRalpha transfected in green monkey CV1 cells after 48 hrs by reporter gene assay
Agonist activity at Xenopus laevis THRalpha transfected in green monkey CV1 cells after 48 hrs by reporter gene assay
|
[PMID: 32356658] |
| CV-1 | EC50 |
1.2 nM
Compound: T3
|
Agonist activity at human THRbeta expressed in green monkey CV1 cells after 24 hrs by luciferase assay
Agonist activity at human THRbeta expressed in green monkey CV1 cells after 24 hrs by luciferase assay
|
[PMID: 32356658] |
| HEK293 | EC50 |
0.41 nM
Compound: T3
|
Agonist activity at human thyroid hormone receptor alpha expressed in HEK293 cells by luciferase reporter gene assay
Agonist activity at human thyroid hormone receptor alpha expressed in HEK293 cells by luciferase reporter gene assay
|
[PMID: 25305688] |
| HEK-293T | EC50 |
5.8 μM
Compound: T3
|
Agonist activity at recombinant human pFA-CMV fused PPARgamma expressed in HEK293T cells transfected with pFR-luciferase plasmid and pRL-SV40 plasmid incubated for 14 to 16 hrs by dual glo luciferase reporter gene assay
Agonist activity at recombinant human pFA-CMV fused PPARgamma expressed in HEK293T cells transfected with pFR-luciferase plasmid and pRL-SV40 plasmid incubated for 14 to 16 hrs by dual glo luciferase reporter gene assay
|
[PMID: 32356658] |
| HeLa | EC50 |
2.4 nM
Compound: T3
|
Effect on human TRalpha transactivation activity in HeLa cells by luciferase reporter assay
Effect on human TRalpha transactivation activity in HeLa cells by luciferase reporter assay
|
[PMID: 17988877] |
| HeLa | EC50 |
2.4 nM
Compound: T3
|
Effect on human TRbeta transactivation activity in HeLa cells by luciferase reporter assay
Effect on human TRbeta transactivation activity in HeLa cells by luciferase reporter assay
|
[PMID: 17988877] |
| LNCaP | IC50 |
>50 μM
Compound: 6, T3
|
Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis
Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis
|
[PMID: 22047606] |
| Oocyte | IC50 |
50.4 μM
Compound: Triiodothyronine
|
TP_TRANSPORTER: inhibition of Digoxin uptake in Xenopus laevis oocytes
TP_TRANSPORTER: inhibition of Digoxin uptake in Xenopus laevis oocytes
|
[PMID: 11561088] |
| Sf9 | EC50 |
0.5 nM
Compound: T3
|
Agonist activity at human THRalpha expressed in baculovirus infected SF9 cells after 15 mins by gel electrophoresis
Agonist activity at human THRalpha expressed in baculovirus infected SF9 cells after 15 mins by gel electrophoresis
|
[PMID: 32356658] |
| U2OS | EC50 |
11 nM
Compound: T3
|
Effect on human TRbeta transactivation activity in U2OS cells by luciferase reporter assay
Effect on human TRbeta transactivation activity in U2OS cells by luciferase reporter assay
|
[PMID: 17988877] |
| U2OS | EC50 |
2.4 nM
Compound: T3
|
Effect on human TRalpha transactivation activity in U2OS cells by luciferase reporter assay
Effect on human TRalpha transactivation activity in U2OS cells by luciferase reporter assay
|
[PMID: 17988877] |
Liothyronine (GMP) can be used in culture medium for generation of induced pluripotent stem cells from human keratinocytes[1].
Liothyronine (GMP) is necessary in limbal stem cells (LSCs) proliferation and self-renewal[2].
Liothyronine (GMP) (4 nM) promotes cardiac differentiation and maturation of embryonic stem cells[3].
Liothyronine (GMP) (100 Nm, 14 days) promotes electrophysiological maturation of human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 6893-02-3
-
Appearance Solid
-
Molecular Weight 650.97
-
Formula C15H12I3NO4
-
Color White to off-white
-
SMILES
OC1=C(I)C=C(OC2=C(I)C=C(C[C@H](N)C(O)=O)C=C2I)C=C1
-
Synonyms
Triiodothyronine (GMP); 3,3',5-Triiodo-L-thyronine (GMP); T3 (GMP)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
Purity & Documentation
-
Data Sheet (271 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Aasen T, et al. Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells. Nat Protoc. 2010 Feb;5(2):371-82. [Content Brief]
[2]. Yu M, et al. An important role for adenine, cholera toxin, hydrocortisone and triiodothyronine in the proliferation, self-renewal and differentiation of limbal stem cells in vitro. Exp Eye Res. 2016 Nov;152:113-122. [Content Brief]
[3]. CY, et al. Triiodothyronine promotes cardiac differentiation and maturation of embryonic stem cells via the classical genomic pathway. Mol Endocrinol. 2010 Sep;24(9):1728-36. [Content Brief]
[4]. Wang L, et al. Triiodothyronine and dexamethasone alter potassium channel expression and promote electrophysiological maturation of human-induced pluripotent stem cell-derived cardiomyocytes. J Mol Cell Cardiol. 2021 Dec;161:130-138. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)